Recombinant Human S100A16, N-His

Description of Recombinant Human S100A16, N-His

Introduction to Recombinant Human S100A16

Recombinant Human S100A16 is a protein that belongs to the S100 family of calcium-binding proteins. It is encoded by the S100A16 gene and is expressed in various tissues, including the heart, liver, and brain. This protein has been found to have important roles in cellular processes such as cell growth, differentiation, and apoptosis. In this article, we will explore the structure, activity, and applications of Recombinant Human S100A16.

Structure of Recombinant Human S100A16

Recombinant Human S100A16 is a small protein with a molecular weight of approximately 10 kDa. It is composed of 91 amino acids and has a conserved EF-hand calcium-binding domain. This domain is responsible for the calcium-dependent conformational changes that are crucial for the activity of S100 proteins. The structure of Recombinant Human S100A16 also includes a C-terminal extension that is unique to this protein and is involved in its cellular localization and function.

Activity of Recombinant Human S100A16

Recombinant Human S100A16 has been shown to have a diverse range of activities in different cellular processes. One of its main functions is its role in regulating cell growth and proliferation. Studies have shown that this protein can stimulate cell proliferation in certain types of cancer cells, such as breast cancer and colon cancer. It achieves this by interacting with other proteins and signaling pathways involved in cell growth and division.

In addition to its role in cell growth, Recombinant Human S100A16 has also been found to be involved in cell differentiation. It has been shown to promote the differentiation of osteoblasts, which are cells responsible for bone formation. This suggests that this protein may have potential applications in bone regeneration and repair.

Recombinant Human S100A16 has also been linked to the process of apoptosis, or programmed cell death. It has been found to interact with proteins involved in apoptosis, such as Bcl-2 and caspases, and may play a role in regulating this process. This suggests that this protein may have potential applications in cancer therapy by promoting cell death in cancer cells.

Applications of Recombinant Human S100A16

Due to its diverse range of activities, Recombinant Human S100A16 has potential applications in various fields, including cancer research, tissue engineering, and drug development. Its role in promoting cell proliferation and differentiation makes it a potential target for cancer therapy and bone regeneration. It can also be used as a biomarker for certain types of cancer, as its expression has been found to be upregulated in breast and colon cancer cells.

Furthermore, Recombinant Human S100A16 has been investigated as a potential therapeutic target for other diseases, such as diabetes and neurodegenerative disorders. It has been found to play a role in insulin secretion and glucose metabolism, and its expression has been linked to Alzheimer’s disease and Parkinson’s disease. This suggests that this protein may have potential applications in the treatment of these conditions.

Conclusion

In summary, Recombinant Human S100A16 is a small protein with a conserved EF-hand calcium-binding domain and a unique C-terminal extension. It has been found to have diverse activities in regulating cell growth, differentiation, and apoptosis. Its potential applications in cancer therapy, tissue engineering, and drug development make it a promising target for further research and development. With ongoing studies and advancements in recombinant protein technology, Recombinant Human S100A16 may hold great potential for future therapeutic interventions.